{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:24Z","timestamp":1787020704851,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB216116"],"award-info":[{"award-number":["20232BAB216116"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212BAB216062"],"award-info":[{"award-number":["20212BAB216062"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260946"],"award-info":[{"award-number":["82260946"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-06404-9","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:21:39Z","timestamp":1764332499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The N-butanol extract of modified Yanghe decoction alleviates ferroptosis in bone marrow mesenchymal stem cells in glucocorticoid-induced osteoporosis by activating the HIF-1\u03b1\/GPX4 signaling pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Fengyun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanguang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"6404_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","volume":"29","author":"J Vandewalle","year":"2018","unstructured":"Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 2018;29:42\u201354.","journal-title":"Trends Endocrinol Metab"},{"key":"6404_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41584-020-0370-z","volume":"16","author":"F Buttgereit","year":"2020","unstructured":"Buttgereit F. Views on glucocorticoid therapy in rheumatology: the age of convergence. Nat Rev Rheumatol. 2020;16:239\u201346.","journal-title":"Nat Rev Rheumatol"},{"key":"6404_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15:993\u20131000.","journal-title":"J Bone Miner Res"},{"key":"6404_CR4","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00198-013-2352-3","volume":"24","author":"SR Majumdar","year":"2013","unstructured":"Majumdar SR, Morin SN, Lix LM, Leslie WD. Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study. Osteoporos Int. 2013;24:2493\u20138.","journal-title":"Osteoporos Int"},{"key":"6404_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/BOR.0000000000000608","volume":"31","author":"G Adami","year":"2019","unstructured":"Adami G, Saag KG. Glucocorticoid-induced osteoporosis update. Curr Opin Rheumatol. 2019;31:388\u201393.","journal-title":"Curr Opin Rheumatol"},{"key":"6404_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","volume":"16","author":"P Chotiyarnwong","year":"2020","unstructured":"Chotiyarnwong P, McCloskey EV. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol. 2020;16:437\u201347.","journal-title":"Nat Rev Endocrinol"},{"key":"6404_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.03.002","volume":"70","author":"M Chen","year":"2023","unstructured":"Chen M, Fu W, Xu H, Liu CJ. Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Cytokine Growth Factor Rev. 2023;70:54\u201366.","journal-title":"Cytokine Growth Factor Rev"},{"key":"6404_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57101119","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Giorgino R, Hildebrand F, Spiezia F, Peretti GM, Alessandri-Bonetti M, et al. Fragility fractures: risk factors and management in the elderly. Medicina (Kaunas). 2021. https:\/\/doi.org\/10.3390\/medicina57101119.","journal-title":"Medicina (Kaunas)"},{"key":"6404_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-024-05301-x","volume":"19","author":"M Andersen","year":"2024","unstructured":"Andersen M, Andresen AK, Hartvigsen J, Hermann AP, S\u00f8rensen J, Carreon LY. Vertebroplasty for painful osteoporotic vertebral compression fractures: a protocol for a single-center doubled-blind randomized sham-controlled clinical trial. VOPE2. J Orthop Surg Res. 2024;19:813.","journal-title":"J Orthop Surg Res"},{"key":"6404_CR10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1186\/s13018-024-05295-6","volume":"19","author":"L Shen","year":"2024","unstructured":"Shen L, Yang H, Zhou F, Jiang T, Jiang Z. Risk factors of short-term residual low back pain after PKP for the first thoracolumbar osteoporotic vertebral compression fracture. J Orthop Surg Res. 2024;19:792.","journal-title":"J Orthop Surg Res"},{"key":"6404_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M, et al. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res. 2018;33:190\u20138.","journal-title":"J Bone Miner Res"},{"key":"6404_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bmb\/ldac017","volume":"143","author":"F Migliorini","year":"2022","unstructured":"Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis. Br Med Bull. 2022;143:46\u201356.","journal-title":"Br Med Bull"},{"key":"6404_CR13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s43465-025-01396-4","volume":"59","author":"V Shetty","year":"2025","unstructured":"Shetty V, Agashe V, Mishra S, Kambli M, Jain M, Dhawale R. Unitized nail-plate construct (NPC) for atypical femur fracture fixation: a retrospective study on clinical outcomes. Indian J Orthop. 2025;59:945\u201350.","journal-title":"Indian J Orthop"},{"key":"6404_CR14","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/ijms16035452","volume":"16","author":"V Conti","year":"2015","unstructured":"Conti V, Russomanno G, Corbi G, Toro G, Simeon V, Filippelli W, et al. A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy. Int J Mol Sci. 2015;16:5452\u201366.","journal-title":"Int J Mol Sci"},{"key":"6404_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s13018-021-02678-x","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021;16:533.","journal-title":"J Orthop Surg Res"},{"key":"6404_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17512433.2021.1851192","volume":"14","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Colarossi G, Baroncini A, Eschweiler J, Tingart M, Maffulli N. Pharmacological management of postmenopausal osteoporosis: a level i evidence based - expert opinion. Expert Rev Clin Pharmacol. 2021;14:105\u201319.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6404_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13018-021-02497-0","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, Peretti GM, Tingart M, Giorgino R. Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16:351.","journal-title":"J Orthop Surg Res"},{"key":"6404_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13018-021-02474-7","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, Tingart M, Maria PG, Riccardo G. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16:318.","journal-title":"J Orthop Surg Res"},{"key":"6404_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1186\/s13018-024-05361-z","volume":"19","author":"X Bao","year":"2024","unstructured":"Bao X, Liu C, Liu H, Wang Y, Xue P, Li Y. Association between polymorphisms of glucagon-like peptide-1 receptor gene and susceptibility to osteoporosis in Chinese postmenopausal women. J Orthop Surg Res. 2024;19:869.","journal-title":"J Orthop Surg Res"},{"key":"6404_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s13018-024-05287-6","volume":"19","author":"J Leeyaphan","year":"2024","unstructured":"Leeyaphan J, Rojjananukulpong K, Intarasompun P, Peerakul Y. Simple clinical predictors for making directive decisions in osteoporosis screening for women: a cross-sectional study. J Orthop Surg Res. 2024;19:789.","journal-title":"J Orthop Surg Res"},{"key":"6404_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science"},{"key":"6404_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020360","author":"L Hu","year":"2018","unstructured":"Hu L, Yin C, Zhao F, Ali A, Ma J, Qian A. Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19020360.","journal-title":"Int J Mol Sci"},{"key":"6404_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.12659\/MSM.897044","volume":"22","author":"C Wang","year":"2016","unstructured":"Wang C, Meng H, Wang X, Zhao C, Peng J, Wang Y. Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci Monit. 2016;22:226\u201333.","journal-title":"Med Sci Monit"},{"key":"6404_CR24","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1210\/en.2005-0717","volume":"147","author":"C Swanson","year":"2006","unstructured":"Swanson C, Lorentzon M, Conaway HH, Lerner UH. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. Endocrinology. 2006;147:3613\u201322.","journal-title":"Endocrinology"},{"key":"6404_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s13287-019-1498-0","volume":"10","author":"L Han","year":"2019","unstructured":"Han L, Wang B, Wang R, Gong S, Chen G, Xu W. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor. Stem Cell Res Ther. 2019;10:377.","journal-title":"Stem Cell Res Ther"},{"key":"6404_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.348","volume":"4","author":"J Li","year":"2013","unstructured":"Li J, Zhang N, Huang X, Xu J, Fernandes JC, Dai K, et al. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C\/EBPalpha promoter methylation. Cell Death Dis. 2013;4:e832.","journal-title":"Cell Death Dis"},{"key":"6404_CR27","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.3390\/cells11192979","volume":"11","author":"L Gao","year":"2022","unstructured":"Gao L, Hua W, Tian L, Zhou X, Wang D, Yang Y, et al. Molecular mechanism of Ferroptosis in orthopedic diseases. Cells. 2022;11:2979.","journal-title":"Cells"},{"key":"6404_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111836","volume":"165","author":"Z Gao","year":"2022","unstructured":"Gao Z, Chen Z, Xiong Z, Liu X. Ferroptosis - a new target of osteoporosis. Exp Gerontol. 2022;165:111836.","journal-title":"Exp Gerontol"},{"key":"6404_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ph11040107","author":"E Balogh","year":"2018","unstructured":"Balogh E, Paragh G, Jeney V. Influence of iron on bone homeostasis. Pharmaceuticals (Basel). 2018. https:\/\/doi.org\/10.3390\/ph11040107.","journal-title":"Pharmaceuticals (Basel)"},{"key":"6404_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13287-025-04326-1","volume":"16","author":"Y Xu","year":"2025","unstructured":"Xu Y, Zhang L, Xu X, Tao Y, Xue P, Wang Y, et al. Targeting prominin-2\/BACH1\/GLS pathway to inhibit oxidative stress-induced ferroptosis of bone mesenchymal stem cells. Stem Cell Res Ther. 2025;16:213.","journal-title":"Stem Cell Res Ther"},{"key":"6404_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101259","volume":"12","author":"K Chen","year":"2025","unstructured":"Chen K, Tao H, Xiao H, Chu M, Zhu P, Lv S, et al. Identification of ferroptosis\/autophagy-related genes and potential underlying mechanisms involved in the effect of BMSC senescence on the osteogenic differentiation of aging BMSCs. Genes Dis. 2025;12:101259.","journal-title":"Genes Dis"},{"key":"6404_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41420-023-01653-1","volume":"9","author":"X He","year":"2023","unstructured":"He X, Wang D, Yi Y, Tan Y, Wu M, Wang H, et al. \u0394-tocotrienol preconditioning improves the capability of bone marrow-derived mesenchymal stem cells in promoting wound healing by inhibiting BACH1-related ferroptosis. Cell Death Discov. 2023;9:349.","journal-title":"Cell Death Discov"},{"key":"6404_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121326","volume":"322","author":"J Xiao","year":"2023","unstructured":"Xiao J, Zhang G, Chen B, He Q, Mai J, Chen W, et al. Quercetin protects against iron overload-induced osteoporosis through activating the Nrf2\/HO-1 pathway. Life Sci. 2023;322:121326.","journal-title":"Life Sci"},{"key":"6404_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120601","volume":"306","author":"J Song","year":"2023","unstructured":"Song J, Zhang Y, Zhu Y, Jin X, Li L, Wang C, et al. Structural characterization and anti-osteoporosis effects of polysaccharide purified from Eucommia ulmoides Oliver cortex based on its modulation on bone metabolism. Carbohydr Polym. 2023;306:120601.","journal-title":"Carbohydr Polym"},{"key":"6404_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176244","volume":"965","author":"S Xiang","year":"2024","unstructured":"Xiang S, Zhao L, Tang C, Ling L, Xie C, Shi Y, et al. Icariin inhibits osteoblast ferroptosis via Nrf2\/HO-1 signaling and enhances healing of osteoporotic fractures. Eur J Pharmacol. 2024;965:176244.","journal-title":"Eur J Pharmacol"},{"key":"6404_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109708","volume":"122","author":"H Xia","year":"2020","unstructured":"Xia H, Cao D, Yang F, Yang W, Li W, Liu P, et al. Jiawei Yanghe decoction ameliorates cartilage degradation in vitro and vivo via Wnt\/\u03b2-catenin signaling pathway. Biomed Pharmacother. 2020;122:109708.","journal-title":"Biomed Pharmacother"},{"key":"6404_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2885419","volume":"2022","author":"Y Luo","year":"2022","unstructured":"Luo Y, Xia H, Wang J, Hu Q, Luo Y, Liu J, et al. Jiawei yanghe decoction regulates bone-lipid balance through the BMP-SMAD signaling pathway to promote osteogenic differentiation of bone mesenchymal stem cells. Evid Based Complement Alternat Med. 2022;2022:2885419.","journal-title":"Evid Based Complement Alternat Med"},{"key":"6404_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156764","volume":"142","author":"X Wan","year":"2025","unstructured":"Wan X, Xu P, Zhou X, Liu J, Yang Y, Liang C, et al. Qi-Gu capsule alleviates osteoporosis by inhibiting mesenchymal stem cell senescence via the HIF-1\u03b1\/AMPK axis. Phytomedicine. 2025;142:156764.","journal-title":"Phytomedicine"},{"key":"6404_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.711004","volume":"12","author":"R Xu","year":"2021","unstructured":"Xu R, Zeng Q, Xia C, Chen J, Wang P, Zhao S, et al. Fractions of Shen-Sui-Tong-Zhi formula enhance osteogenesis via activation of \u03b2-catenin signaling in growth plate chondrocytes. Front Pharmacol. 2021;12:711004.","journal-title":"Front Pharmacol"},{"key":"6404_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70705","volume":"29","author":"P Peng","year":"2025","unstructured":"Peng P, Wong P, Lv Z, Tian J, He W, Wei Q, et al. Tectorigenin ameliorates glucocorticoid-induced osteoporosis by inhibiting the NF-\u03baB signal pathway and modulating Treg-Th17 cell balance. J Cell Mol Med. 2025;29:e70705.","journal-title":"J Cell Mol Med"},{"key":"6404_CR41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s13018-025-06043-0","volume":"20","author":"M Shi","year":"2025","unstructured":"Shi M, Sun P, Chai F. Epimedium brevicornu and Curculigo orchioides inhibit osteoclast autophagy by degrading the level of miRNA-199 to regulate the mTOR signaling pathway. J Orthop Surg Res. 2025;20:631.","journal-title":"J Orthop Surg Res"},{"key":"6404_CR42","doi-asserted-by":"crossref","unstructured":"Davis BJ, Rosenberg BM, Kearney MG, Treanor M, Craske MG, Barry TJ: Pharmacological enhancement of fear extinction. Trends Cogn Sci 2025.","DOI":"10.1016\/j.tics.2025.06.011"},{"key":"6404_CR43","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1210\/en.2004-1050","volume":"146","author":"FS Wang","year":"2005","unstructured":"Wang FS, Lin CL, Chen YJ, Wang CJ, Yang KD, Huang YT, et al. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology. 2005;146:2415\u201323.","journal-title":"Endocrinology"},{"key":"6404_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41420-025-02633-3","volume":"11","author":"HT Hu","year":"2025","unstructured":"Hu HT, Zhang ZY, Luo Z, Ti HB, Wu JJ, Nie H, et al. Emerging regulated cell death mechanisms in bone remodeling: decoding ferroptosis, cuproptosis, disulfidptosis, and PANoptosis as therapeutic targets for skeletal disorders. Cell Death Discov. 2025;11:335.","journal-title":"Cell Death Discov"},{"key":"6404_CR45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbrc.2022.02.112","volume":"602","author":"F Sun","year":"2022","unstructured":"Sun F, Zhou JL, Liu ZL, Jiang ZW, Peng H. Dexamethasone induces ferroptosis via P53\/SLC7A11\/GPX4 pathway in glucocorticoid-induced osteonecrosis of the femoral head. Biochem Biophys Res Commun. 2022;602:149\u201355.","journal-title":"Biochem Biophys Res Commun"},{"key":"6404_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414902","author":"Y Shi","year":"2025","unstructured":"Shi Y, Tang Q, Sheng S, Jiang H, Jin C, Zhou C, et al. PSMD14 stabilizes SLC7A11 to ameliorate glucocorticoid-induced osteoporosis by suppressing osteocyte ferroptosis. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202414902.","journal-title":"Adv Sci"},{"key":"6404_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002783","author":"Y Hu","year":"2025","unstructured":"Hu Y, Lu H, Fang H, Chen B, Chen Z, Jiang M, et al. Targeting SIRT3 to regulate mitophagy-dependent ferroptosis for preventing glucocorticoid-induced osteoporosis. Int J Surg. 2025. https:\/\/doi.org\/10.1097\/JS9.0000000000002783.","journal-title":"Int J Surg"},{"key":"6404_CR48","doi-asserted-by":"publisher","first-page":"16130","DOI":"10.1038\/s41598-019-52513-x","volume":"9","author":"J Lu","year":"2019","unstructured":"Lu J, Yang J, Zheng Y, Chen X, Fang S. Extracellular vesicles from endothelial progenitor cells prevent steroid-induced osteoporosis by suppressing the ferroptotic pathway in mouse osteoblasts based on bioinformatics evidence. Sci Rep. 2019;9:16130.","journal-title":"Sci Rep"},{"key":"6404_CR49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41419-025-07883-8","volume":"16","author":"W Hu","year":"2025","unstructured":"Hu W, Cai Y, Cai D, Chen Z, Huang S, Zhang S, et al. HIF-1\u03b1 alleviates ferroptosis in ulcerative colitis by regulation of GPX4. Cell Death Dis. 2025;16:542.","journal-title":"Cell Death Dis"},{"key":"6404_CR50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40478-025-02069-x","volume":"13","author":"Z Liu","year":"2025","unstructured":"Liu Z, Sun L, Gao N, Li W, Pang L. Reciprocal regulation of GPNMB\/HIF-1\u03b1 for inhibition of neuronal ferroptosis in delayed encephalopathy after acute carbon monoxide poisoning. Acta Neuropathol Commun. 2025;13:154.","journal-title":"Acta Neuropathol Commun"},{"key":"6404_CR51","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.2147\/DDDT.S480514","volume":"18","author":"J Ding","year":"2024","unstructured":"Ding J, Wang BY, Yang YF, Kuai LY, Wan JJ, Zhang M, et al. Ciprofol Ameliorates Myocardial Ischemia\/Reperfusion Injury by Inhibiting Ferroptosis Through Upregulating HIF-1\u03b1. Drug Des Devel Ther. 2024;18:6115\u201332.","journal-title":"Drug Des Devel Ther"},{"key":"6404_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114841","volume":"159","author":"W Li","year":"2025","unstructured":"Li W, Liu Y, Wei M, Yang Z, Tang H, Huang W. Chondrocyte-targeted \u03b1-solanine through HIF-1\u03b1 regulating glycolysis to reduce the ferroptosis of chondrocyte in osteoarthritis. Int Immunopharmacol. 2025;159:114841.","journal-title":"Int Immunopharmacol"},{"key":"6404_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70580","volume":"29","author":"P Kang","year":"2025","unstructured":"Kang P, Zhou X, Zhao S, Yu W, Ye Z, Cheng F. Inhibitors of p53 apoptosis-stimulating protein mitigate acute kidney injury by modulating the HIF-1\u03b1\/SLC7A11 pathway to suppress ferroptosis. J Cell Mol Med. 2025;29:e70580.","journal-title":"J Cell Mol Med"},{"key":"6404_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112893","volume":"142","author":"C Chen","year":"2024","unstructured":"Chen C, Chen B, Lin Y, He Q, Yang J, Xiao J, et al. Cardamonin attenuates iron overload-induced osteoblast oxidative stress through the HIF-1\u03b1\/ROS pathway. Int Immunopharmacol. 2024;142:112893.","journal-title":"Int Immunopharmacol"},{"key":"6404_CR55","volume":"16","author":"S Nunkoo","year":"2024","unstructured":"Nunkoo S, Krissheeven M, Chitravanshi A, Ramanah M, Robinson J, Banerjee I. Clinical efficacy and safety of teriparatide versus alendronate in postmenopausal osteoporosis: a systematic review of randomized controlled trials. Cureus. 2024;16:e73068.","journal-title":"Cureus"},{"key":"6404_CR56","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/jcm10071403","volume":"10","author":"B Hauser","year":"2021","unstructured":"Hauser B, Alonso N, Riches PL. Review of current real-world experience with teriparatide as treatment of osteoporosis in different patient groups. J Clin Med. 2021;10:1403.","journal-title":"J Clin Med"},{"key":"6404_CR57","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1021\/acs.jafc.2c05632","volume":"71","author":"C Jin","year":"2023","unstructured":"Jin C, Tan K, Yao Z, Lin BH, Zhang DP, Chen WK, et al. A novel anti-osteoporosis mechanism of VK2: interfering with ferroptosis via AMPK\/SIRT1 pathway in type 2 diabetic osteoporosis. J Agric Food Chem. 2023;71:2745\u201361.","journal-title":"J Agric Food Chem"},{"key":"6404_CR58","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s13018-024-05320-8","volume":"19","author":"F Huang","year":"2024","unstructured":"Huang F, Wang Y, Liu J, Cheng Y, Zhang X, Jiang H. Asperuloside alleviates osteoporosis by promoting autophagy and regulating Nrf2 activation. J Orthop Surg Res. 2024;19:855.","journal-title":"J Orthop Surg Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06404-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-06404-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06404-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T14:15:57Z","timestamp":1764339357000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-025-06404-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6404"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-06404-9","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1049"}}